跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,533 条关于
“DUX4 protein”
全部
12,533
临床试验
5,631
药物
1,240
机构
53
资讯
5,609
去年
Avidity Biosciences' Del-brax Trial Enrolls New Cohort for Accelerated FSHD Approval
去年
Epicrispr Biotechnologies Doses First Patient with EPI-321, Novel Epigenetic Therapy for Facioscapulohumeral Muscular Dystrophy
去年
Arrowhead Pharmaceuticals Receives $100 Million Milestone Payment for ARO-DM1 Myotonic Dystrophy Treatment
去年
First-in-Human Gene Therapy Trial Launches for Rare Muscle Disorder FSHD
去年
Avidity Biosciences Advances Delpacibart Braxlosiran for FSHD with Biomarker Cohort
5个月前
O'Shaughnessy Ventures Backs Bioengineer Developing Gene Therapy for Rare Muscular Dystrophy She Lives With
去年
Avidity Biosciences Advances Delpacibart Braxlosiran for FSHD with Biomarker Cohort
2年前
Fulcrum Therapeutics' Losmapimod Fails Phase 3 Trial in FSHD, Development Suspended
去年
RNA Therapy Market Set to Reach $4.16 Billion by 2034 as Clinical Trials Accelerate
去年
Avidity Biosciences Advances AOC 1020 for FSHD with Biomarker Cohort in FORTITUDE Trial
第 1 页,共 561 页
上一页
下一页